GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Maat Pharma SA (XPAR:MAAT) » Definitions » Sale Of Investment

Maat Pharma (XPAR:MAAT) Sale Of Investment : €0.01 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Maat Pharma Sale Of Investment?

Maat Pharma's sale of investment for the six months ended in Dec. 2023 was €-0.01 Mil. It means Maat Pharma gained €-0.01 Mil from selling investments. Maat Pharma's sale of investment for the trailing twelve months (TTM) ended in Dec. 2023 was €0.01 Mil.

Compared with last quarter (€0.02 Mil in Jun. 2023 ), Maat Pharma gained less money from selling investments in Dec. 2023 (€-0.01 Mil).


Maat Pharma Sale Of Investment Historical Data

The historical data trend for Maat Pharma's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Maat Pharma Sale Of Investment Chart

Maat Pharma Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Investment
Get a 7-Day Free Trial - - - - 0.01

Maat Pharma Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 0.02 -0.01

Maat Pharma Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.01 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Maat Pharma Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Maat Pharma's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Maat Pharma Business Description

Traded in Other Exchanges
N/A
Address
70 Avenue Tony Garnier, Lyon, FRA, 69007
Maat Pharma SA is a french clinical stage biotech and a pioneer in the development of microbiome based ecosystem therapies dedicated to improving survival outcomes for patients with cancer.

Maat Pharma Headlines

No Headlines